## Clinical Diagnosis **Key Point:** This patient has symptomatic mitral stenosis (MS) with a mitral valve area (MVA) of 1.2 cm², which is in the severe range (normal >4 cm²; moderate 1.5–2.5 cm²; severe <1.5 cm²). ## Hemodynamic Assessment The patient demonstrates: - Dyspnea on exertion (Class II–III functional limitation) - Loud S1 (high-velocity mitral closure) - Opening snap 80 ms after A2 (indicates pliable leaflets; snap >120 ms suggests calcification) - Diastolic murmur (turbulent flow across stenotic orifice) - Pulmonary edema on imaging (elevated LA pressure) ## Management Algorithm ```mermaid flowchart TD A[Symptomatic MS with MVA < 1.5 cm²]:::outcome --> B{Valve morphology suitable?}:::decision B -->|Pliable, no calcification, no LA thrombus| C[Percutaneous Mitral Balloon Valvotomy]:::action B -->|Calcified, rigid, LA thrombus, or MR| D[Surgical Mitral Valve Replacement]:::action C --> E[Excellent outcomes in young patients]:::outcome D --> F[Reserved for unfavorable anatomy]:::outcome ``` **High-Yield:** In young patients with favorable valve morphology (pliable leaflets, minimal calcification, no LA thrombus, no significant MR), **percutaneous mitral balloon valvotomy (PMBV)** is the procedure of choice over surgery. This patient's opening snap at 80 ms indicates pliable leaflets. ## Why PMBV is Preferred Here | Feature | PMBV | Surgical Replacement | |---------|------|---------------------| | **Invasiveness** | Percutaneous, catheter-based | Open surgery | | **Valve preservation** | Yes | No (prosthetic needed) | | **Durability** | 10–15 years; repeat if needed | Prosthetic lifespan issues | | **Anticoagulation** | Not required (unless AF) | Lifelong (mechanical) | | **Pregnancy** | Safe after successful PMBV | Risky with prosthetics | | **Ideal patient** | Young, pliable valve, no thrombus | Calcified, rigid, MR present | **Clinical Pearl:** The opening snap timing is a surrogate for valve compliance. A snap <80 ms suggests a pliable valve; >120 ms suggests calcification and stiffness. This patient's 80 ms snap is favorable for PMBV. ## Contraindications to PMBV - Significant mitral regurgitation (>2+) - LA thrombus (requires anticoagulation first) - Heavily calcified, immobile leaflets - Severe subvalvular disease - Hemodynamic instability or cardiogenic shock **Mnemonic: PMBV Suitability — FLAT** - **F**avorable anatomy (pliable leaflets) - **L**ow calcification score (Wilkins score <8) - **A**bsence of LA thrombus - **T**rivial to mild MR Medical therapy (diuretics, beta-blockers, anticoagulation) is temporizing and does not halt disease progression; it is appropriate for asymptomatic mild MS or as a bridge to intervention. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.